Cancer news
'Cross-talk' mechanism contributes to colorectal cancer
Nov 13, 2009 |
5 / 5 (1) |
0
Researchers at the University of Wisconsin-Madison School of Medicine and Public Health have identified a molecular mechanism that allows two powerful signaling pathways to interact and begin a process leading to colorectal ...
Researchers 'notch' a victory toward new kind of cancer drug
Nov 11, 2009 |
4.3 / 5 (3) |
1
(PhysOrg.com) -- Scientists have devised an innovative way to disarm a key protein considered to be "undruggable," meaning that all previous efforts to develop a drug against it have failed. Their discovery, published in ...
Researchers find a weak link in cancer cell armor
Nov 11, 2009 |
5 / 5 (4) |
0
(PhysOrg.com) -- Professor Robert Weiss has found that when two particular genes are inhibited, cancer cells are destroyed at a greater rate. The study is published in the Nov. 9 issue of PNAS.
Drug shrinks lung cancer tumors in mice
Nov 10, 2009 |
4.8 / 5 (6) |
0
(PhysOrg.com) -- A potential new drug for lung cancer has eliminated tumours in 50% of mice in a new study published today in the journal Cancer Research. In the animals, the drug also stopped lung cancer ...
Hundreds of genes distinguish patients likely to survive advanced melanoma
Nov 09, 2009 |
not rated yet |
0
Although the chances of surviving advanced melanoma aren't very good with current therapies, some patients can live for years with cancer that has spread beyond the skin to other organs. Now it may be possible to identify ...
Researchers find two units of umbilical cord blood reduce risk of leukemia recurrence
Nov 13, 2009 |
4 / 5 (1) |
0
A new study from the Masonic Cancer Center, University of Minnesota shows that patients who have acute leukemia and are transplanted with two units of umbilical cord blood (UCB) have significantly reduced risk of the disease ...
Paradoxical protein might prevent cancer
Nov 13, 2009 |
not rated yet |
0
(PhysOrg.com) -- One difficulty with fighting cancer cells is that they are similar in many respects to the body's stem cells. By focusing on the differences, researchers at Karolinska Institutet have found a new way of tackling ...
Genetic changes shown to be important indicators for disease progression in cervical cancer patients
Nov 13, 2009 |
not rated yet |
0
Cervical cancer patients with specific changes in the cancer genome have a three- or fourfold increased risk of relapse after standard treatment compared to patients without these changes, according to a study by Norwegian ...
Australian bid to 'regrow' breasts after cancer surgery
Nov 12, 2009 |
5 / 5 (1) |
0
Australian scientists said Thursday they were to trial a revolutionary treatment which would allow women to regrow their breasts after cancer surgery.
New mechanism explains how the body prevents formation of blood vessels
Nov 11, 2009 |
4 / 5 (1) |
0
Researchers at Uppsala University, in collaboration with colleagues in Sweden and abroad, have identified an entirely new mechanism by which a specific protein in the body inhibits formation of new blood vessels. Inhibiting ...
Drugs to treat anemia in cancer patients linked to thromboembolism
Nov 10, 2009 |
2.5 / 5 (2) |
1
Medications frequently given to cancer patients to reduce their risk of anemia are associated with an increased risk of deep vein thrombosis or pulmonary embolism, according to new research led by Dawn Hershman, M.D, M.S., ...
FDA approved leukemia drugs shows promise in ovarian cancer cells
Nov 10, 2009 |
not rated yet |
0
The drug Sprycel, approved for use by the U.S. Food and Drug Administration in patients with chronic myeloid leukemia, significantly inhibited the growth and invasiveness of ovarian cancer cells and also promoted their death, ...
Routine evaluation of prostate size not as effective in cancer screening (w/ Video)
Nov 10, 2009 |
not rated yet |
0
New Mayo Clinic research studied the association between prostate-specific antigen (PSA) levels and prostate size and found that routine annual evaluation of prostate growth is not necessarily a predictor for the development ...
FDA-approved drugs eliminate, prevent cervical cancer in mice
Nov 09, 2009 |
not rated yet |
0
Researchers at the University of Wisconsin-Madison School of Medicine and Public Health have eliminated cervical cancer in mice with two FDA-approved drugs currently used to treat breast cancer and osteoporosis.
For young boys with cancer, testicular tissue banking may be option to preserve fertility
Nov 09, 2009 |
not rated yet |
0
For parents of children with cancer, the hopeful news is that pediatric survival rates have steadily improved for decades. Among the bad news—treatments that enable survival often cause infertility.
